TVTX — Travere Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Travere Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	362	553	450	567	371
Net Total Accounts Receivable
Net Total Receivables	33.1	16.2	16.6	21.2	27.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	410	583	486	617	417
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	35.1	34.3	30	25.5	19.6
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	607	777	673	789	594
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	92.7	124	142	178	201
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	396	475	630	588	535
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	211	302	42.9	201	59.1
Total Liabilities & Shareholders' Equity	607	777	673	789	594
Total Common Shares Outstanding